Congenital stenosis of bronchus
ICD-10 Q32.3 is a billable code used to indicate a diagnosis of congenital stenosis of bronchus.
Congenital stenosis of the bronchus refers to a narrowing of the bronchial tubes that occurs at birth. This condition can lead to significant respiratory distress in neonates and infants due to impaired airflow to the lungs. The stenosis may be localized or affect a larger segment of the bronchus, and it can be associated with other congenital anomalies of the respiratory system, such as tracheoesophageal fistula, choanal atresia, or lung hypoplasia. Diagnosis is typically made through imaging studies, such as chest X-rays or CT scans, and may require bronchoscopy for direct visualization. Treatment often involves surgical intervention to correct the narrowing and improve airflow, which is critical for adequate oxygenation and overall health in affected infants. Early detection and management are essential to prevent complications such as recurrent respiratory infections or chronic lung disease.
Pediatric documentation must include detailed descriptions of respiratory symptoms, diagnostic imaging results, and any surgical interventions performed.
Common scenarios include infants presenting with respiratory distress, failure to thrive, or recurrent pneumonia due to bronchial stenosis.
Consideration must be given to the age of the patient and the potential for growth-related changes in bronchial anatomy.
Genetic documentation should include family history, genetic testing results, and any syndromic associations with congenital bronchial stenosis.
Scenarios may involve genetic counseling for families with a history of congenital malformations or syndromes associated with bronchial anomalies.
Genetic coders must be aware of the potential for chromosomal abnormalities that may present with respiratory malformations.
Used for diagnosis and assessment of bronchial stenosis.
Document indication for bronchoscopy and findings.
Pediatric pulmonologists often perform this procedure.
Accurate coding of congenital bronchial stenosis is crucial for appropriate treatment planning, resource allocation, and tracking of congenital anomalies. It also impacts reimbursement and quality of care metrics.
